Skip to main content

Study M595

Study name

Cherix A 2020

Title

Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine

Overall design

The aim of this study was to investigate the ability of acetyl-L-carnitine (LAC) supplementation to protect vulnerable mice against stress induced depressive-like behaviors. C57BL/6J mice were divided into the following 3 groups: (1) control group, (2) CRS group, and (3) CRS + acetyl-L-carnitine group (stressor plus acetyl-L-carnitine treatment at a concentration of 0.3% in the drinking water). The CRS stress procedure lasted for 3 weeks, and LAC was administered during the last week of the model building period. The metabolic impact in the nucleus accumbens of antidepressant LAC treatment in chronically stressed mice was investigated using 1H-magnetic resonance spectroscopy (n = 5-6 per group). Metabolite quantification was reported relative to brain water concentration.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Mouse; C57BL/6J mouse;

Categories of depression

Animal model; Chronic restraint stress model; Chronic restraint stress model;

Criteria for depression

Forced swimming test, social interaction test

Sample size

16

Tissue

Central; Brain; Nucleus accumbens;

Platform

MRS; MRS: horizontal 14.1T/26 cm Varian magnet (Agilent Inc, USA);

PMID

31922486

DOI

10.7554/eLife.50631

Citation

Cherix A, Larrieu T, Grosse J, et al. Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine. Elife. 2020;9:e50631.

Metabolite

N-Acetyl-L-aspartic acid;

L-Glutamic acid;

L-Glutamine;

L-Aspartic acid;

Taurine;

Phosphorylcholine;

Phosphocreatine;

Glycerophosphorylcholine/Phosphocholine ratio;